Drug
Functional Magnetic Resonance Imaging
Functional Magnetic Resonance Imaging: highest development phase Phase 2, developed by Supernus Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Supernus Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| Functional Magnetic Resonance Imaging (fMRI) NCT03638466 | Phase 2 | Attention Deficit Hyperactivity Disorder (ADHD) |
Latest
No recent events.
Follow Functional Magnetic Resonance Imaging on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.